Wny Asset Management, LLC Eli Lilly & CO Transaction History

Wny Asset Management, LLC

$826 Million
Q3 2024

A detailed history of Wny Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wny Asset Management, LLC holds 4,944 shares of LLY stock, worth $3.93 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

4,944

Previous 4,959 0.3%

Holding current value

$3.93 Million

Previous $4.49 Million 2.43%

% of portfolio

0.53%

Previous 0.62%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $11,582 - $14,400	-15 Reduced 0.3%	4,944 $4.38 Million
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $83,360 - $104,539	115 Added 2.37%	4,959 $4.49 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $8,883 - $11,884	-15 Reduced 0.31%	4,844 $3.77 Million
Q3 2023 Dec 14, 2023	SELL	$434.7 - $599.3 $2,173 - $2,996	-5 Reduced 0.1%	4,859 $2.61 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $3,507 - $4,689	10 Added 0.21%	4,864 $2.28 Million
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $69,133 - $80,554	-215 Reduced 4.24%	4,854 $0
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $15,713 - $17,907	-53 Reduced 1.03%	5,069 $1.64 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $557 - $654	-2 Reduced 0.04%	5,122 $1.66 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $22,485 - $27,904	100 Added 1.99%	5,124 $1.42 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $11,080 - $13,635	-50 Reduced 0.99%	5,024 $1.16 Million
Q2 2021 Jul 14, 2021	BUY	$180.55 - $233.54 $902 - $1,167	5 Added 0.1%	5,074 $1.16 Million
Q1 2021 Apr 20, 2021	BUY	$164.32 - $212.72 $832,938 - $1.08 Million	5,069 New	5,069 $947,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wny Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wny Asset Management, LLC with notifications on news.

Account

Wny Asset Management, LLC Eli Lilly & CO Transaction History